FLNA
Filana Therapeutics, Inc. - Common Stock (FLNA)
$82
About Filana Therapeutics, Inc. - Common Stock (FLNA)
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Details
Daily high
$0.85
Daily low
$0.80
Price at open
$0.82
52 Week High
$4.98
52 Week Low
$0.80
Market cap
40.0M
Dividend yield
-
Volume
1,218
Avg. volume
255,550
P/E ratio
-.95
Filana Therapeutics, Inc. - Common Stock News
Details
Daily high
$0.85
Daily low
$0.80
Price at open
$0.82
52 Week High
$4.98
52 Week Low
$0.80
Market cap
40.0M
Dividend yield
-
Volume
1,218
Avg. volume
255,550
P/E ratio
-.95